Literature DB >> 10566392

An information system to promote intravenous-to-oral medication conversion.

J M Teich1, A M Petronzio, J R Gerner, D L Seger, C Shek, J Fanikos.   

Abstract

Many inpatients remain on expensive intravenous medications, even after they become able to take bioequivalent oral alternatives. We developed a computer intervention to identify such patients and to deliver alerts suggesting a switch to the oral medication. In the first phase of the project, alerts were delivered to pharmacists. The Brigham Integrated Computer System (BICS) was used to produce a daily report of patients receiving any of six targeted intravenous medications, who also had orders for an oral diet or other scheduled oral medications. Staff pharmacists screened the report and suggested IV to PO conversion in appropriate cases to the patient's nurses and/or physicians. Feedback was documented in the BICS system. Analysis of the pilot study showed that in 31.7% of cases, physicians agreed to change (or had just changed) the patient's medication from IV to PO. Further analysis of pilot (Phase I) data was performed against a variety of parameters in order to increase the fraction of alerts deemed appropriate for conversion. These more specific alerts can be sent directly to physicians.

Entities:  

Mesh:

Year:  1999        PMID: 10566392      PMCID: PMC2232681     

Source DB:  PubMed          Journal:  Proc AMIA Symp        ISSN: 1531-605X


  8 in total

1.  Implementation of physician order entry: user satisfaction and self-reported usage patterns.

Authors:  F Lee; J M Teich; C D Spurr; D W Bates
Journal:  J Am Med Inform Assoc       Date:  1996 Jan-Feb       Impact factor: 4.497

2.  Automated evidence-based critiquing of orders for abdominal radiographs: impact on utilization and appropriateness.

Authors:  L H Harpole; R Khorasani; J Fiskio; G J Kuperman; D W Bates
Journal:  J Am Med Inform Assoc       Date:  1997 Nov-Dec       Impact factor: 4.497

3.  Cost savings and avoidance from clinical interventions.

Authors:  A H Mutnick; K J Sterba; J A Peroutka; N E Sloan; E A Beltz; M K Sorenson
Journal:  Am J Health Syst Pharm       Date:  1997-02-15       Impact factor: 2.637

4.  Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report.

Authors:  A K Jha; G J Kuperman; J M Teich; L Leape; B Shea; E Rittenberg; E Burdick; D L Seger; M Vander Vliet; D W Bates
Journal:  J Am Med Inform Assoc       Date:  1998 May-Jun       Impact factor: 4.497

5.  Development of an intravenous-to-oral route conversion program for antimicrobial therapy at a Canadian tertiary care health facility.

Authors:  M T Zamin; M M Pitre; J M Conly
Journal:  Ann Pharmacother       Date:  1997-05       Impact factor: 3.154

6.  A pharmacist-initiated program of intravenous to oral antibiotic conversion.

Authors:  K G Przybylski; M J Rybak; P R Martin; C M Weingarten; F K Zaran; J G Stevenson; D P Levine
Journal:  Pharmacotherapy       Date:  1997 Mar-Apr       Impact factor: 4.705

7.  Effect of computerized physician order entry and a team intervention on prevention of serious medication errors.

Authors:  D W Bates; L L Leape; D J Cullen; N Laird; L A Petersen; J M Teich; E Burdick; M Hickey; S Kleefield; B Shea; M Vander Vliet; D L Seger
Journal:  JAMA       Date:  1998-10-21       Impact factor: 56.272

8.  Physician inpatient order writing on microcomputer workstations. Effects on resource utilization.

Authors:  W M Tierney; M E Miller; J M Overhage; C J McDonald
Journal:  JAMA       Date:  1993-01-20       Impact factor: 56.272

  8 in total
  9 in total

1.  Overriding of drug safety alerts in computerized physician order entry.

Authors:  Heleen van der Sijs; Jos Aarts; Arnold Vulto; Marc Berg
Journal:  J Am Med Inform Assoc       Date:  2005-12-15       Impact factor: 4.497

2.  An incremental pharmacy informatics model for use in a rural hospital.

Authors:  Douglas A Talbert; Edward Roush; Luis Velazco; Casey White
Journal:  AMIA Annu Symp Proc       Date:  2005

3.  A roadmap for national action on clinical decision support.

Authors:  Jerome A Osheroff; Jonathan M Teich; Blackford Middleton; Elaine B Steen; Adam Wright; Don E Detmer
Journal:  J Am Med Inform Assoc       Date:  2007-01-09       Impact factor: 4.497

4.  Development and evaluation of a comprehensive clinical decision support taxonomy: comparison of front-end tools in commercial and internally developed electronic health record systems.

Authors:  Adam Wright; Dean F Sittig; Joan S Ash; Joshua Feblowitz; Seth Meltzer; Carmit McMullen; Ken Guappone; Jim Carpenter; Joshua Richardson; Linas Simonaitis; R Scott Evans; W Paul Nichol; Blackford Middleton
Journal:  J Am Med Inform Assoc       Date:  2011-03-17       Impact factor: 4.497

5.  A trial of inpatient indication based prescribing during computerized order entry with medications commonly used off-label.

Authors:  S M Walton; W L Galanter; H Rosencranz; D Meltzer; R S Stafford; F Tiryaki; D Sarne
Journal:  Appl Clin Inform       Date:  2011-03-09       Impact factor: 2.342

6.  Identification of Patients Eligible for IV-to-PO Conversion: A Cost-Minimization Study.

Authors:  Merisa Mok; Angus Kinkade; Anthony Tung; Aaron M Tejani
Journal:  Can J Hosp Pharm       Date:  2016-08-31

7.  Return on investment for a computerized physician order entry system.

Authors:  Rainu Kaushal; Ashish K Jha; Calvin Franz; John Glaser; Kanaka D Shetty; Tonushree Jaggi; Blackford Middleton; Gilad J Kuperman; Ramin Khorasani; Milenko Tanasijevic; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2006-02-24       Impact factor: 4.497

8.  Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies.

Authors:  Julie Downen; Cassie Jaeger
Journal:  BMJ Open Qual       Date:  2020-01

9.  Impact of printed antimicrobial stewardship recommendations on early intravenous to oral antibiotics switch practice in district hospitals.

Authors:  Wei T Sze; Mei C Kong
Journal:  Pharm Pract (Granada)       Date:  2018-06-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.